These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9447855)

  • 21. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
    Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
    Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, multicentre, double-blind, placebo-controlled trial of the use of aprotinin in the repair of ruptured abdominal aortic aneurysm. On behalf of the Joint Vascular Research Group.
    Robinson J; Nawaz S; Beard JD
    Br J Surg; 2000 Jun; 87(6):754-7. PubMed ID: 10848853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aprotinin on postoperative blood loss in off-pump coronary artery bypass surgery.
    Durand M; Chavanon O; Tessier Y; Meyer C; Casez M; Bach V; Maitrasse B; Girardet P
    J Card Surg; 2006; 21(1):17-21. PubMed ID: 16426342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery.
    Parvizi R; Azarfarin R; Hassanzadeh S
    Saudi Med J; 2007 Jan; 28(1):49-53. PubMed ID: 17206289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
    Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced blood loss by aprotinin in thoracic surgical operations associated with high risk of bleeding. A placebo-controlled, randomized phase IV study.
    Kyriss T; Wurst H; Friedel G; Jaki R; Toomes H
    Eur J Cardiothorac Surg; 2001 Jul; 20(1):38-41. PubMed ID: 11423271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of effects of aprotinin and tranexamic acid on blood loss in heart surgery].
    Corbeau JJ; Monrigal JP; Jacob JP; Cottineau C; Moreau X; Bukowski JG; Subayi JB; Delhumeau A
    Ann Fr Anesth Reanim; 1995; 14(2):154-61. PubMed ID: 7486272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials.
    Shiga T; Wajima Z; Inoue T; Sakamoto A
    Anesth Analg; 2005 Dec; 101(6):1602-1607. PubMed ID: 16301226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery: a prospective, double-blind, randomised and placebo-controlled study.
    Jeserschek R; Clar H; Aigner C; Rehak P; Primus B; Windhager R
    J Bone Joint Surg Br; 2003 Mar; 85(2):174-7. PubMed ID: 12678347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
    Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
    Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of beneficial effect of acute normovolemic hemodilution combined with aprotinin on allogeneic blood transfusion requirements in cardiac surgery.
    Höhn L; Schweizer A; Licker M; Morel DR
    Anesthesiology; 2002 Feb; 96(2):276-82. PubMed ID: 11818756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
    Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
    Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of aprotinin in aortocoronary bypass and valve replacement operations: a placebo-controlled randomized double-blind study.
    Rodrigus IE; Vermeyen KM; De Hert SG; Amsel BJ; Walter PJ
    Perfusion; 1996 Jul; 11(4):313-8. PubMed ID: 8884859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
    Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
    Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
    Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
    Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, placebo-controlled, double-blind study of an ultra-low-dose aprotinin regimen in reoperative and/or complex cardiac operations.
    Hardy JF; Bélisle S; Couturier A; Robitaille D
    J Card Surg; 1997; 12(1):15-22. PubMed ID: 9169364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty.
    Langdown AJ; Field J; Grote J; Himayat H
    J Arthroplasty; 2000 Dec; 15(8):1009-12. PubMed ID: 11112196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aprotinin decreases blood loss in patients undergoing revision or bilateral total hip arthroplasty.
    Murkin JM; Shannon NA; Bourne RB; Rorabeck CH; Cruickshank M; Wyile G
    Anesth Analg; 1995 Feb; 80(2):343-8. PubMed ID: 7529467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group.
    Porte RJ; Molenaar IQ; Begliomini B; Groenland TH; Januszkiewicz A; Lindgren L; Palareti G; Hermans J; Terpstra OT
    Lancet; 2000 Apr; 355(9212):1303-9. PubMed ID: 10776742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aprotinin and classic wound drainage are unnecessary in total hip replacement - a prospective randomized trial.
    Fleischmann F; Matuschek C; Orth K; Gerber PA; Mota R; Knoefel WT; Peiper M; Schick M; van Griensven M; Bölke E; Fleischmann W
    Eur J Med Res; 2011 Jan; 16(1):20-8. PubMed ID: 21345766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.